Dados B3 › QUSW3 × TIMS3 · Português
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | QUSW3 | TIMS3 | year |
|---|---|---|---|
| ROE | 27.6%! | 0.0%! | 2024 |
| ROIC | 24.9%! | 0.0%! | 2024 |
| ROA | 10.1%! | 0.0%! | 2024 |
| Gross margin | 100.0%! | 51.8% | 2023 |
| EBIT margin | 60.9%! | 19.8% | 2023 |
| Net margin | 29.2%! | 11.9% | 2023 |
| Net debt/EBITDA | 1.07x! | -0.11x | 2023 |
| Current ratio | 1.43x! | 0.89x | 2023 |
| Revenue growth (1y) | 0.1%! | -100.0%! | 2024 |
| Revenue growth (5y CAGR) | -10.7%! | 47.9%! | 2023 |
| Piotroski F-Score | 4/9! | 1/9! | 2025 |
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | QUSW3 | TIMS3 | year |
|---|---|---|---|
| P/E | — | — | None × 2023 |
| P/B | — | 1.69x | None × 2023 |
| EV/EBITDA | — | 3.60x | None × 2023 |
| FCF yield | — | 18.0% | None × 2023 |
Numbers on this page are live. Data version 2026-09-01-supressao-declarada · page generated 2026-09-08 14:48 UTC. If this does not match /saude, you are reading a cached copy.
Home · Methodology · Transparency · Audit it